U.S. Online Retail and Ecommerce Stock News

SpaceX’s record US$75b IPO and US$2t market cap have grabbed headlines, but the ripple effects may matter more for you as an investor. Fresh enthusiasm for mega-IPOs and high-growth stories is colliding with questions about rich valuations and business risk. That mix of optimism and caution is now spilling over into other recently listed large caps that could one day qualify for major indices. This article highlights 3 stocks from our Index Inclusion Beneficiaries screener that are especially...

Structure Therapeutics (GPCR) drew attention after publishing Phase 2b ACCESS trial data for its oral GLP-1 candidate aleniglipron in Nature Medicine, alongside a detailed presentation at the American Diabetes Association’s 86th Scientific Sessions. See our latest analysis for Structure Therapeutics. The latest data release has arrived against a mixed price backdrop, with the stock at US$42.93 after a strong 7 day share price return of 14.24%. This contrasts with a weaker 90 day share price...

Recent price performance and business mix Icahn Enterprises (IEP) has seen its unit price decline about 10% over the past month and about 5% over the past 3 months, drawing attention to how its diversified operations are currently valued. The partnership spans multiple businesses, including investment funds, energy refining and renewables, automotive services and parts, food packaging, real estate, home fashion and pharma. As a result, the stock reflects a mix of cyclical and defensive...

Geopolitics and market mood behind WEBTOON’s latest move The prospect of a US Iran peace deal eased geopolitical risk and supported a broad shift into risk assets, with WEBTOON Entertainment (WBTN) rising alongside other digital media and content platform stocks. The move came as investors also responded to more supportive credit conditions and lower perceived rate hike odds, rather than any company specific news or fresh disclosure from WEBTOON itself. See our latest analysis for WEBTOON...

The record setting SpaceX IPO has not only grabbed headlines, it has also reshuffled attention across mega cap growth stocks. A US$2.1b market cap debut, heavy index inclusion, unusually high retail access and a unique lockup structure are all feeding new trading patterns that can reward or punish investors who are not paying attention to where flows are heading. This article highlights 3 mega cap growth stocks exposed to these cross‑currents, explaining how the SpaceX listing could influence...

STAAR Surgical (NasdaqGM:STAA) reported outstanding Q1 results, with revenue up 120% year on year. The company delivered the fastest revenue growth and largest analyst estimate beat among its specialty medical device peers. The Q1 performance highlights a significant operational milestone and stronger business momentum for the company. STAAR Surgical's Q1 update lands against a mixed share price backdrop. The stock closed at $28.37, with the share price up 20.2% year to date and up 66.1%...

Stevanato Group stock reaction and recent context Stevanato Group (STVN) shares recently closed at US$17.08, with the stock down about 5% over the past month but up roughly 11% over the past 3 months. See our latest analysis for Stevanato Group. Zooming out, the stock’s 11.27% 90 day share price return contrasts with a year to date share price decline of 17.01%, and a 1 year total shareholder return decline of 26.99%. This suggests that recent momentum is improving after a weaker longer term...

Curbline Properties Corp. recently raised fresh capital by filing an at-the-market follow-on equity program of up to US$400 million and completing US$120.27 million in common stock issuances at modest discounts to market. This move, combined with an analyst upgrade reflecting improved earnings expectations, highlights how Curbline is using equity markets to support its growth plans while sentiment around its business strengthens. Next, we’ll examine how Curbline’s at-the-market equity...

In early June 2026, SciTec Inc. announced it was selected by the U.S. Department of the Air Force PAE C3BM office to deliver a US$5.5 million operational data fusion system option under the Cloud-Based Command and Control program, building on an initial US$24.0 million award from 2024. This win highlights how SciTec’s cloud-based fusion software, now part of Firefly Aerospace, is being embedded in critical U.S. defense command-and-control infrastructure, reinforcing Firefly’s exposure to...

Atmus Filtration Technologies (ATMU) is back in focus after its late 2025 purchase of Koch Filter Corp, a move that is expected to lift EBITDA margins and EPS as the industrial filtration push takes shape. See our latest analysis for Atmus Filtration Technologies. The stock has recently moved out of a softer patch, with the 90-day share price return down 13.03% and the 30-day share price return down 3.56%. More recently, it has shown a stronger near-term tone, reflected in a 7-day share price...

Forestar Group (NYSE:FOR) is under pressure as persistently weak sales trends, negative free cash flow, and falling returns on capital raise concerns about recent investment decisions. These financial and operational strains point to possible value destruction from new projects and capital deployment. The situation is drawing fresh attention because it has not been widely discussed, despite potential implications for investor confidence and management credibility. For a company with a...

First Ottawa Bancshares (FOTB) opened 2026 with Q1 revenue of US$19.4 million and basic EPS of US$24.46, alongside trailing 12 month revenue of US$75.6 million and EPS of US$27.05 that frame the latest quarter in a wider earnings run. Over recent periods, the company has seen revenue move from US$16.3 million in Q1 2025 to US$19.4 million in Q1 2026, while trailing 12 month EPS has shifted from US$20.79 at Q4 2024 to US$27.05 at Q1 2026. This sets the stage for investors to focus on how...

If you are wondering whether Clorox stock is starting to offer value again, the recent share price and valuation signals are giving you a fresh set of data points to weigh up. The stock last closed at US$96.82, with returns of 2.8% over the past week and 7.0% over the past month, while being down 4.0% year to date and 17.8% over the past year, as well as 30.9% and 33.6% over the past 3 and 5 years respectively. Recent news coverage has largely focused on Clorox's position in household...

Hexcel (NYSE:HXL) has entered a new long term industrial partnership with Deutsche Aircraft to supply composite solutions for the D328eco regional turboprop. The agreement covers advanced composite materials for primary and secondary structures on the D328eco, a next generation aircraft focused on environmental efficiency. The partnership was formalized at a major aerospace event and positions Hexcel within a key European program in regional aviation. For investors watching NYSE:HXL, this...

Why Tandem Diabetes Care Stock Is Back on Investor Radars Tandem Diabetes Care (TNDM) has drawn fresh attention after recent share price swings, with the stock up about 29% over the past month but down roughly 24% in the past 3 months. See our latest analysis for Tandem Diabetes Care. At a share price of $16.60, Tandem Diabetes Care has seen a 5.06% 1 day share price gain and a 29.49% 30 day share price return. This follows a 24.24% 90 day decline and a 22.97% year to date share price...

UiPath (NYSE:PATH) reported that its Maestro platform has been used by One New Zealand Limited to revamp a complex telecom workflow. The deployment enabled near real-time mobile provisioning while keeping existing legacy systems in place. One New Zealand is now extending Maestro to additional mission critical processes after the initial rollout. For investors watching UiPath, this case highlights the company’s core pitch as an orchestration layer for automation and AI agents in large,...

Wondering whether Globus Medical at around US$80.39 still offers value or if the easy money has already been made? This article breaks down what the current price might be implying about the stock. Globus Medical has returned 0.5% over the past week and 4.9% over the past month, while year to date the stock is down 7.9% and up 36.5% over the past year. Recent coverage has focused on how Globus Medical fits into broader interest in medical technology and healthcare equipment, as investors...

For investors wondering whether Trane Technologies at around US$458 per share still offers value, or if most of the easy gains are already behind it, this article focuses squarely on what the current price might imply. The stock has risen 15.1% year to date and 9.8% over the past year, on top of very large gains over the last 3 years and 181.6% over 5 years. It therefore makes sense to ask what that track record might mean for the current valuation. Recent coverage has described Trane...

RH (RH) opened Q1 2027 with revenue of US$800.3 million and a loss per share of US$0.73, compared with Q1 2026 revenue of US$814.0 million and EPS of US$0.43, setting a mixed tone for the quarter. Over the same period, trailing twelve month revenue moved from US$3.27 billion to US$3.43 billion while trailing EPS went from US$4.52 to US$5.49. This gives you a broader view of how the top and bottom lines have evolved around this latest print. With trailing net margins edging up and forecasts...

Hilton Grand Vacations completed a $300 million securitization of timeshare loans. The transaction packages timeshare receivables into securities sold to investors. This move adds another funding source alongside existing capital tools such as equity and buybacks. For investors watching NYSE:HGV, this securitization comes with the stock trading around $50.78 and showing firm trailing returns, including up 32.6% over the past year and up 19.3% over five years. The deal speaks directly to how...

Pilgrim's Pride (NasdaqGS:PPC) is investing in its Ellijay, Georgia facility to expand and modernize operations. As part of the same move, the company is closing the harvesting portion of its Chattanooga, Tennessee plant. The changes focus production more heavily on higher value, boneless chicken products to align with current consumer preferences. Pilgrim's Pride operates across the chicken production chain, from live operations to processed products, and this facility shift ties directly...

Velo3D (VELO) has drawn fresh attention after filing a roughly US$97.3 million shelf registration for 4,290,000 shares of common stock related to an employee stock ownership plan, and appointing Lily Mei to its Board of Directors. See our latest analysis for Velo3D. The stock has been volatile, with a 7 day share price return of 60.88% and a 90 day share price return of 80.85%. The 1 year total shareholder return is very large, but the 3 and 5 year total shareholder returns remain deeply...

XPeng’s X9 electric MPV achieved best-in-class range and charging performance in El Prix 2026, Europe’s largest independent real world EV test. The vehicle recorded the highest positive deviation versus WLTP range among all participants. The X9 also posted the fastest real world charging time in the test field. These results strengthen XPeng’s (NYSE:XPEV) visibility with European consumers and EV observers. XPeng, listed as NYSE:XPEV, focuses on smart electric vehicles and has been working...

At the 2026 ASCO meeting, Immatics reported extended Phase 1 and 1b data showing deep, durable responses and manageable safety for its PRAME-targeted cell therapies and IMA401 bispecific across multiple hard-to-treat solid tumors, reinforcing progress of its lead programs in advanced melanoma, gynecologic cancers, synovial sarcoma, and head and neck cancer. A distinctive takeaway is how Immatics is building an integrated PRAME franchise, spanning TCR T-cell therapies and bispecifics, aimed...